Adele has opened up about her health after experiencing a flare-up of her spinal condition during her Las Vegas residency. During one of the “Hello” singer’s recent concerts - as part of her “Weekends with Adele” residency at The Colosseum at Caesars Palace - she explained to fans that before stepping on stage, she had fallen and was unable to move due to a sciatica attack. A sciatica flare-up comes from the sciatic nerve when it is compressed or irritated. When this happens, a person can experience pain that radiates from their lower back all the way down to their feet. “They picked my whole body up off the floor,” Adele explained to the crowd, according toThe Sun. The singer also revealed to the audience that she had to take a break mid-show over the weekend, saying: “I am going to sit down and rest my sciatica.” This isn’t the first time the “Easy on Me” singer has spoken openly about her health. During a performance on New Year’s Eve last December, Adele struggled to walk across the stage as she explained her chronic back pain and sciatica. “I have to waddle these days as I have really bad sciatica," she said at the time. Not only was she struggling to walk, but she also shared that she was performing with a disintegrated disc in her spine. “Is anyone else kind of my age starting getting bad knees? I have got really bad sciatica in my left leg and my L5 disc is not f***ing there anymore. It’s worn away,” she said back in February. The L5 spinal nerve provides sensation to the outer side of the lower leg, the upper part of the foot, and the space between the first and second toe. The nerve also controls hip, knee, foot and toe movements, according to the Cleveland Clinic. The sciatic nerve consists of the L4 and L5 nerves plus other sacral nerves, the website states. In an interview with Elle last year, Adele also said that she slipped her L6 disc when her son, Angelo, jumped out to scare her as she came out of the bathroom. The singer previously toldThe Face magazine in a November 2021 interview that her back issues go back to her teenage years. “I slipped my first disc when I was 15 from sneezing. I was in bed and I sneezed and my fifth one flew out. In January, I slipped my sixth one, my L6. And then when I had a C‑section, my core was useless," she said. Adele explained that she had lived with back pain for most of her life, and that her flare-ups occurred when she was stressed or continuously sitting with bad posture. However, she revealed that key to improving her symptoms was regularly working out. “Where I got my tummy strong, down at the bottom, which I never had before, my back doesn’t play up as much,” Adele said. “It means I can do more, I can run around with my kid a little bit more.” Read More Adele halts show to rebuke security guard hassling a fan: ‘Leave him alone’ Adele says she wants to have a baby with boyfriend Rich Paul ‘soon’ Miley Cyrus was ‘thinking of Adele’ while writing new song ‘Used to Be Young’

Chinese customers flocked to Apple stores to buy the latest iPhone 15 despite government restrictions and local competition,

Initially the deaths of kittens were considered to be disease-related but testing results on multiple specimens found no sign of disease

Gold is facing tough competition this year as the preferred haven for cautious investors.

Joe Alwyn has attended a dinner hosted by Celine artistic director Hedi Slimane during the 2023 Cannes Film Festival. The British actor was photographed at the event at Hotel du Cap-Eden Roc on Monday night (22 May). It marks the 32-year-old’s first appearance at a public event since he and Taylor Swift reportedly split up in April after six years together. Alwyn, who has writing credits for several of Swift’s songs under the pseudonym William Bowery, stepped out in a pale pink satin button-down shirt, a black suit jacket and black trousers. Other celebrities who attended the fashion house’s intimate dinner included model Kaia Gerba, Blackpink member Lisa, and BTS member V. Neither Alwyn nor Swift, 33, have publicly addressed or confirmed their break-up. The pair preferred to keep their relationship private when they were dating and rarely spoke about one another with the press. Entertainment Tonight first reported the split, quoting a source as saying that the “relationship had just run its course” and that the split was “not dramatic”. Another source told People on 10 April that the couple “had rough patches before and always worked things out, so friends thought they would take some time apart but eventually come back together”. However, the couple “ultimately” decided that they “weren’t the right fit for one another”, the source added. The “We Are Never Ever Getting Back Together” singer is currently on her Eras Tour, which began on 18 March and is set to end on 9 August. Alwyn, who usually attended Swift’s shows in support of the singer, had not been seen at any of her concerts since the tour began. Swift sparked rumours that she has been dating The 1975 frontman Matty Healy after he appeared at several of her shows and joined Phoebe Bridgers on-stage to open the pop star’s show in Nashville. Healy, 34, played the guitar during Bridgers’ song “Motion Sickness”. The two musicians have been spotted multiple times together since she ended things with Alwyn, including at several locations in New York City. This week, Swift told her audience in Foxborough, Massachusetts, that she has “never been this happy in my life in all aspects of my life ever” amid the rumoured romance. A video shared to TikTok showed the singer saying: “It’s not just a tour, I just sort of feel like my life finally feels like it makes sense. So I thought I’d play this song which brings me a lot of happy memories.” Read More Maya Hawke raises eyebrows at Cannes as she pirouettes down red carpet Taylor Swift tells fans she’s ‘never been this happy’ amid rumoured Matty Healy romance Sylvester Stallone’s daughters call Rocky star a ‘savant’ when it comes to their dating lives Taylor Swift tells fans she’s ‘never been this happy’ amid Matty Healy rumours Let’s not judge Taylor and Matty – rebound relationships aren’t always doomed Taylor Swift fans in dismay over new photo ‘confirming’ Matty Healy romance

Creative Artists Agency is in advanced discussions to sell a majority stake in itself to Francois-Henri Pinault, the

The federal government has opened civil rights investigations at seven schools and universities over allegations of antisemitism or Islamophobia since the outbreak of the Israel-Hamas war

U.S. Surgeon General Dr. Vivek Murthy issued an advisory Tuesday declaring what many families already

By Katherine Masters NEW YORK Retailers such as Macy's and Columbia Sportswear are expanding their use of "breathable"

One of the scientists whose work pioneered the development of medications such as Ozempic and Wegovy has revealed why life may become “so miserably boring” after two years of using the drug. Ozempic is an FDA-approved medication used for the treatment of type 2 diabetes. It works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), which regulates blood sugar levels and slows down the rate at which food leaves the stomach, often creating the feeling of fullness. These semaglutide injections – sold under the brand names Ozempic and Wegovy – have soared in popularity as many people, including Hollywood celebrities, have used it for weight loss. What’s more, people have also found Ozempic has been effective in curing their addictive habits, like drinking, smoking, shopping, or nail biting. However, because of Ozempic’s increasing popularity, it has led to national shortages of the type 2 diabetes treatment – leaving those who actually need it without. In an interview with Wired, professor Jens Juul Holst – who received the Warren Alpert Foundation Prize in 2021 for his work developing treatments based on the GLP-1 hormone – spoke about the effects of Ozempic, and why he believes many people will stop taking the medication after just a few years. “What happens is that you lose your appetite and also the pleasure of eating, and so I think there’s a price to be paid when you do that,” Holst told Wired. “If you like food, then that pleasure is gone. The craving for food for some people is taken away when they take GLP-1 drugs.” He continued: “That may eventually be a problem, that once you’ve been on this for a year or two, life is so miserably boring that you can’t stand it any longer and you have to go back to your old life.” Holst added that medications like Ozempic and Wegovy have been on the market since 2005, though studies show that these people don’t stay on them for very long. “It’s just like every other drug, they don’t stay on it for many reasons,” he explained. “One of the reasons, as I said, is that once you have tried it and you realise you’ve lost interest in food, then that may be enough.” “We don’t know why people stop taking these drugs, but we know for a fact that they do stop. They do that all over the world.” A 2020 study found that 70 per cent of people who took GLP-1 drugs for type 2 diabetes stopped taking them within two years. However, this could pose a problem for many patients taking semaglutide injections. Research has found that people who stopped taking Ozempic or Wegovy for weight loss experienced weight rebound. A trial published in April 2022 saw participants gain back two thirds of the weight they had lost after 68 weeks of taking semaglutide. As for celebrities who use the once-weekly injection for weight loss, despite not having diabetes or clinical obesity, Hans instead called attention to the “many terrible problems” that those with diabetes have struggled with by not having drugs like Ozempic readily available. “Have you ever visited a diabetes hospital? It’s really deplorable,” he said. “People come in with amputated limbs and compromised cognitive functions and heart problems or they can barely move – they’re miserable and depressed. It’s really serious. There is so much you can improve with a drug that is not only a weight-loss drug but is also an anti-diabetic.” Amidst the popularity of semaglutide injections, the US Food and Drug Administration has issued warnings for consumers not to use off-brand versions of Ozempic or Wegovy, because they may not include the same GLP-1 hormone used in approved medications. Earlier this month, agency officials reported problems with patients using compounded versions of semaglutide – which combines traditional semaglutide with other ingredients. These drugs are not FDA-approved, and the agency does not verify the safety or effectiveness of compounded drugs. Consumers should only use drugs containing semaglutide with a prescription from a licensed health care provider and obtained from a state-licensed pharmacy or other facilities registered with the FDA, the agency said. Read More What is ‘Ozempic face’? Doctors warn about facial ageing side effect of diabetes medications How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss Pregnant Stassi Schroeder admits she wants to ‘try’ Ozempic after giving birth Doctors warn about ‘Ozempic face’ side effect of medications Amy Schumer says she stopped taking Ozempic because of side-effects

Luxury-goods stocks slumped in Europe after Richemont Chairman Johann Rupert said inflation is starting to dent demand across

LOS ANGELES--(BUSINESS WIRE)--Jul 25, 2023--